
Organo Corporation
Organo Corporation (ORGJF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ORGJF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026Next Earnings Date
EPS & Revenue vs. Estimates
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.79 | — | — | — | $0.27B | — |
| ▲ Q2 FY2026 | May 13, 2026 | $1.19 | $1.42 | +19.3% | $0.31B | $0.30B | +4.2% |
| ▼ Q1 FY2026 | Feb 4, 2026 | $1.07 | $0.90 | -16.1% | $0.29B | $0.28B | +3.1% |
| ▲ Q4 FY2025 | Oct 31, 2025 | $0.90 | $1.16 | +28.8% | $0.30B | $0.28B | +6.8% |
| ▼ Q3 FY2025 | Aug 4, 2025 | $0.64 | $0.55 | -14.3% | $0.26B | $0.30B | -11.0% |
| ▲ Q2 FY2025 | May 13, 2025 | $1.27 | $1.52 | +19.7% | $0.33B | $0.25B | +33.5% |
| ▼ Q1 FY2025 | Feb 5, 2025 | $0.87 | $0.81 | -7.7% | $0.26B | $0.28B | -4.3% |
| ▲ Q4 FY2024 | Nov 1, 2024 | $0.68 | $0.80 | +17.5% | $0.29B | $0.29B | -1.5% |
Analyst Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $199.25 | $199.25 | $199.25 | 1 |
| Q4 FY2026 | $173.34 | $173.34 | $173.34 | 1 |
| Q3 FY2026 | $173.34 | $173.34 | $173.34 | 1 |
| Q2 FY2026 | $125.52 | $125.52 | $125.52 | 1 |
| Q1 FY2026 | $190.47 | $190.47 | $190.47 | 1 |
| Q4 FY2025 | $167.21 | $167.21 | $167.21 | 1 |
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $58.8B | $58.8B | $58.8B | 1 |
| Q4 FY2026 | $48.8B | $48.8B | $48.8B | 1 |
| Q3 FY2026 | $52.0B | $52.0B | $52.0B | 1 |
| Q2 FY2026 | $42.9B | $42.9B | $42.9B | 1 |
| Q1 FY2026 | $48.0B | $48.2B | $48.4B | 3 |
| Q4 FY2025 | $42.7B | $43.6B | $44.6B | 3 |
Earnings Price Reaction
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +19.3% | $100.46 | $100.46 | +0.00% |
| ▼ Q1 FY2026 | Feb 4, 2026 | -16.1% | $53.03 | $53.03 | +0.00% |
| ▲ Q4 FY2025 | Oct 31, 2025 | +28.8% | $53.03 | $53.03 | +0.00% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -14.3% | $53.03 | $53.03 | +0.00% |
| ▲ Q2 FY2025 | May 13, 2025 | +19.7% | $53.03 | $53.03 | +0.00% |
| ▼ Q1 FY2025 | Feb 5, 2025 | -7.7% | $57.22 | $53.03 | -7.32% |
| ▲ Q4 FY2024 | Nov 1, 2024 | +17.5% | $27.00 | $27.00 | +0.00% |
| ▼ Q3 FY2024 | Jul 31, 2024 | -3.0% | $27.00 | $27.00 | +0.00% |
About Earnings & Data Methodology
Organo Corporation (ORGJF) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $1.42 — beating the analyst consensus of $1.19 by +19.3%. The next ORGJF earnings date is expected around September 1, 2026.
Each quarter, investors track ORGJF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ORGJF revenue tab →
Frequently asked questions
ORGJF earnings · 5 questionsOrgano Corporation's next earnings report is expected around September 1, 2026. ORGJF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ORGJF historically reports after market close (AMC).
▸ Source: FMP · Organo Corporation SEC filings · US GAAP · Organo Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026